Is TB-500 Legal in Georgia? How to Access It Legally
HealthRX.com
Federal rules do not settle TB-500 legality in Georgia
See the public record for TB-500
At a glance
- FDA approval / None; no approved drug contains TB-500 in any market FDA checked [1]
- FDA pharmacy lists / In none of the three interim categories; not on the bulks list [2][9]
- Outsourcing facility list / Not on it [3]
- Safety-risk page / In the nominated-but-withdrawn table, not the active category 2 table [6]
- HHS draft policy, October 2026 / Covers TB-500 acetate for injection; not binding, not an approval [4][5]
- WADA / Prohibited at all times under S2.3 [7]
- Georgia / The federal documents do not set state law
Is TB-500 legal in Georgia?
The FDA and HHS documents describe federal approval status, compounding-list status, and a draft enforcement policy. They do not decide what Georgia law permits [1][2][3][4][5]. Any Georgia-specific answer would have to come from Georgia's own rules, which this page does not cover.
Under federal compounding rules, a state-licensed pharmacy generally may use only a bulk substance that complies with a USP or National Formulary monograph, is a component of an FDA-approved drug, or appears on FDA's bulks list [8]. TB-500 meets none of the three: FDA found no USP or NF monograph for it and no approved drug containing it, and it is not on the pharmacy bulks list [1][2][9].
Questions worth asking
Where TB-500 sits on FDA's lists
TB-500 is a synthetic 7-amino-acid fragment of the 43-amino-acid protein thymosin beta-4 (residues 17 to 23, N-acetylated), not the full-length protein, and it is sold online as a research-use-only powder [1]. FDA found no pharmacy marketing a compounded TB-500 product [1].
It appears in the nominated-but-withdrawn table on FDA's safety-risk page, not the active category 2 table; removal from category 2 was not a finding that it is safe [6]. In July 2026 FDA staff proposed against adding either the free base or the acetate to the pharmacy bulks list, citing no human data of any kind, no impurity or aggregate data, immunogenicity risk and existing approved wound treatments [1]. FDA's Pharmacy Compounding Advisory Committee voted in favour of adding it on July 23, 2026, against that recommendation; the vote is advice, and placing a substance on the list takes formal rulemaking [9][4].
What the draft federal policy would cover
HHS filed a draft enforcement-discretion policy on October 28, 2026 (Federal Register document 2026-22192, comments due two weeks after the scheduled October 30 publication) naming six peptides, TB-500 among them [4][5]. For TB-500 it covers the acetate form injected subcutaneously or intramuscularly where a single active ingredient, a patient-specific prescription, bulk substance from an FDA-registered manufacturer with a certificate of analysis, and a 'compounded drug product' label are in place [4][5].
The notice says it does not establish rights for any person, is not binding on HHS or the public, and may be revisited, for example after a safety signal [4]. It does not put TB-500 on any list [4]. There is no approved dose and no human dosing study; the nomination FDA reviewed proposed a 3 mg/mL lyophilized powder for injection, a proposed formulation rather than a recommended dose [1].
Safety and testing
FDA's adverse-event search through March 26, 2025 retrieved no TB-500 reports, and its food and supplement complaint system retrieved two cases about a blended TB-500 and BPC-157 product with no safety assessment; FDA found no published case reports, so human safety is unknown [1]. Its stated concern for injectable TB-500 is immunogenicity, and it found no immunogenicity, aggregation or nonclinical toxicity studies [1].
WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3, prohibited at all times, in and out of competition, on both the 2026 and 2027 lists [7][10].
Check what you know
Question 1 of 4
Score: 0 right, 0 of 4 answered
Frequently asked questions
Is TB-500 covered by Georgia law?
Can a Georgia pharmacy compound TB-500 on a prescription?
Do I need a prescription for TB-500?
Was TB-500 made legal in 2026?
References
Show all 10 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Official web page.
- Official web page.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- World Anti-Doping Agency.
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.